Pellets and gummies: Seeking a 3D printed gastro-resistant omeprazole dosage for paediatric administration.
3D printed drugs
3D printed gummies
Medication adherence
Omeprazole
Paediatric medication
Pellets
Personalized medicine
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
25 Aug 2023
25 Aug 2023
Historique:
received:
08
05
2023
revised:
31
07
2023
accepted:
01
08
2023
medline:
21
8
2023
pubmed:
4
8
2023
entrez:
3
8
2023
Statut:
ppublish
Résumé
The production of 3D printed pharmaceuticals has thrived in recent years, as it allows the generation of customised medications in small batches. This is particularly helpful for patients who need specific doses or formulations, such as children. Compounding pharmacies seek alternatives to conventional solid oral doses, opting for oral liquid formulations. However, ensuring quality and stability, especially for pH-sensitive APIs like omeprazole, remains a challenge. This paper presents the application of semi-solid extrusion 3D printing technology to develop patient-tailored medicinal gummies, with an eye-catching appearances, serving as an innovative omeprazole pharmaceutical form for paediatric use. The study compares 3D printing hydrogels with dissolved omeprazole to hydrogels loaded with gastro-resistant omeprazole pellets, a ground-breaking approach.. Gastro-resistance and dissolution profiles were studied using different methods for better comparison and to emphasize the significance of the assay's methodology. Both developed formulas exhibit proper rheology, good printability, and meet content and mass uniformity standards. However, the high gastro-resistance and suitable release profile of 3D printed chewable semi-solid doses with enteric pellets highlight this as an effective strategy to address the challenge of paediatric medication.
Identifiants
pubmed: 37536640
pii: S0378-5173(23)00709-3
doi: 10.1016/j.ijpharm.2023.123289
pii:
doi:
Substances chimiques
Omeprazole
KG60484QX9
Drug Implants
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
123289Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.